Partnership Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.36M Sell
15,708
-487
-3% -$42.9K 0.97% 22
2026
Q2
$1.27M Buy
16,195
+717
+5% +$57.8K 0.86% 24
2026
Q1
$1.34M Sell
15,478
-607
-4% -$58.1K 1.02% 21
2025
Q4
$1.55M Buy
16,085
+759
+5% +$73.7K 1.11% 21
2025
Q3
$1.46M Sell
15,326
-74
-0.5% -$6.8K 1.12% 21
2025
Q2
$1.34M Sell
15,400
-133
-0.9% -$11.3K 1.09% 22
2025
Q1
$1.4M Buy
15,533
+221
+1% +$19.8K 1.18% 21
2024
Q4
$1.22M Buy
15,312
+4,828
+46% +$418K 1.02% 25
2024
Q3
$944K Sell
10,484
-6,007
-36% -$505K 0.67% 30
2024
Q2
$1.3M Sell
16,491
-5,961
-27% -$489K 0.96% 28
2024
Q1
$1.96M Buy
22,452
+21,465
+2,175% +$1.83M 1.37% 26
2023
Q4
$86.4K Buy
+987
New +$75.2K 0.07% 124

Other funds holding MDT

Partnership Wealth Management's MDT Position: Q3 2026 in Review

Partnership Wealth Management reduced its Medtronic (MDT) stake by 3% in Q3 2026, selling an estimated $42.9K and leaving 15,708 shares worth $1.36M. The position accounts for 0.97% of the portfolio, ranked #22.

Partnership Wealth Management first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.96M in Q1 2024. 33 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Partnership Wealth Management held 15,708 shares of Medtronic worth $1.36M as of Q3 2026.
  • Partnership Wealth Management sold 487 Medtronic shares in Q3 2026, an estimated $42.9K.
  • Medtronic made up 0.97% of Partnership Wealth Management's portfolio in Q3 2026, its #22 holding.
  • Partnership Wealth Management first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Partnership Wealth Management's Medtronic position peaked at $1.96M in Q1 2024.
  • 33 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.